Indicators of recent COVID-19 infection status: findings from a large occupational cohort of staff and postgraduate research students from a UK university

[1]  G. Medley,et al.  Public perceptions and interactions with UK COVID-19 Test, Trace and Isolate policies, and implications for pandemic infectious disease modelling , 2022, medRxiv.

[2]  M. Hotopf,et al.  Mental health among UK university staff and postgraduate students in the early stages of the COVID-19 pandemic , 2021, Occupational and Environmental Medicine.

[3]  A. Melidou,et al.  Testing indicators to monitor the COVID-19 pandemic , 2021, The Lancet Infectious Diseases.

[4]  C. Steves,et al.  Risk factors for long COVID: analyses of 10 longitudinal studies and electronic health records in the UK , 2021, medRxiv.

[5]  C. Donnelly,et al.  Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults , 2021, The Lancet Regional Health - Europe.

[6]  Spiros C. Denaxas,et al.  Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource , 2021, BMJ.

[7]  C. Donnelly,et al.  SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic , 2021, Nature Communications.

[8]  J. Danesh,et al.  Accuracy of four lateral flow immunoassays for anti SARS-CoV-2 antibodies: a head-to-head comparative study , 2021, EBioMedicine.

[9]  M. Morshed,et al.  Comparative Analysis of Capillary vs Venous Blood for Serologic Detection of SARS-CoV-2 Antibodies by RPOC Lateral Flow Tests , 2021, Open Forum Infectious Diseases.

[10]  M. Carrillo,et al.  The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[11]  T. Lancet.  Facing up to long COVID , 2020, The Lancet.

[12]  Samuel M. Brown,et al.  Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[13]  C. del Rio,et al.  Long-term Health Consequences of COVID-19. , 2020, JAMA.

[14]  S. Villar,et al.  How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis , 2020, BMJ Open.

[15]  Manish M Patel,et al.  Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee. , 2020, JAMA.

[16]  M. Hotopf,et al.  The King's College London Coronavirus Health and Experiences of Colleagues at King's Study: SARS-CoV-2 antibody response in an occupational sample , 2020, medRxiv.

[17]  G. Alter,et al.  The Power of Antibody-Based Surveillance , 2020, The New England journal of medicine.

[18]  A. Gylfason,et al.  Humoral Immune Response to SARS-CoV-2 in Iceland , 2020, The New England journal of medicine.

[19]  L. Leibovici,et al.  Long-term consequences of COVID-19: research needs , 2020, The Lancet Infectious Diseases.

[20]  Steven F. Baker,et al.  Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant , 2020, Cell Reports Medicine.

[21]  M. Buljan,et al.  SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on , 2020, Journal of Infection.

[22]  Y. Wen,et al.  Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China , 2020, JAMA internal medicine.

[23]  P. Bieniasz,et al.  Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents , 2020, medRxiv.

[24]  T. Hollingsworth,et al.  COVID-19 spread in the UK: the end of the beginning? , 2020, The Lancet.

[25]  S. Riley,et al.  Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey , 2020, Thorax.

[26]  C. Steves,et al.  Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England , 2020, Journal of Infection.

[27]  D. Altmann,et al.  SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection , 2020, Science Immunology.

[28]  Devy M. Emperador,et al.  Antibody tests for identification of current and past infection with SARS‐CoV‐2 , 2020, The Cochrane database of systematic reviews.

[29]  M. Hotopf,et al.  The King's College London Coronavirus Health and Experiences of Colleagues at King's Study (KCL CHECK) protocol paper: a platform for study of the effects of coronavirus pandemic on staff and postgraduate students. , 2020, medRxiv.

[30]  Daniel J. Wilson,et al.  Dynamic linkage of COVID-19 test results between Public Health England’s Second Generation Surveillance System and UK Biobank , 2020, Microbial genomics.

[31]  M. Loeb,et al.  Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  M. Malim,et al.  Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings , 2020, medRxiv.

[33]  N. G. Davies,et al.  Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study , 2020, The Lancet Public Health.

[34]  P. Whiting,et al.  Interpreting a covid-19 test result , 2020, BMJ.

[35]  David A. Drew,et al.  Real-time tracking of self-reported symptoms to predict potential COVID-19 , 2020, Nature Medicine.

[36]  Akihide Ryo,et al.  Interpreting Diagnostic Tests for SARS-CoV-2. , 2020, JAMA.

[37]  P. Bagos,et al.  Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis , 2020, medRxiv.

[38]  Andrew K. Przybylski,et al.  Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science , 2020, The Lancet Psychiatry.

[39]  D. Hand.  Statistical challenges of administrative and transaction data , 2018 .

[40]  H. Wickham.  Read Excel Files , 2015 .

[41]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[42]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[43]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..